Results
|
9081.
|
Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non-small-cell lung cancer xenograft models. [electronic resource] by
- Coxon, Angela
- Ziegler, Beth
- Kaufman, Stephen
- Xu, Man
- Wang, Hongyu
- Weishuhn, Dawn
- Schmidt, Joanna
- Sweet, Heather
- Starnes, Charlie
- Saffran, Douglas
- Polverino, Anthony
Producer: 20130322
In:
Molecular cancer vol. 11
Availability: No items available.
|
|
9082.
|
|
|
9083.
|
Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial. [electronic resource] by
- Ross, Robert W
- Galsky, Matthew D
- Febbo, Phil
- Barry, Marc
- Richie, Jerome P
- Xie, Wanling
- Fennessy, Fiona M
- Bhatt, Rupal S
- Hayes, Julia
- Choueiri, Toni K
- Tempany, Clare M
- Kantoff, Philip W
- Taplin, Mary E
- Oh, William K
Producer: 20121126
In:
Cancer vol. 118
Availability: No items available.
|
|
9084.
|
|
|
9085.
|
|
|
9086.
|
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer. [electronic resource] by
- Crown, J
- Kennedy, M J
- Tresca, P
- Marty, M
- Espie, M
- Burris, H A
- DeSilvio, M
- Lau, M R
- Kothari, D
- Koch, K M
- Diéras, V
Producer: 20140422
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|
|
9087.
|
|
|
9088.
|
|
|
9089.
|
|
|
9090.
|
|
|
9091.
|
The oncological outcomes and risk stratification in docetaxel chemotherapy for castration-resistant prostate cancer. [electronic resource] by
- Shiota, Masaki
- Yokomizo, Akira
- Adachi, Takumi
- Koga, Hirofumi
- Yamaguchi, Akito
- Imada, Kenjiro
- Takeuchi, Ario
- Kiyoshima, Keijiro
- Inokuchi, Junichi
- Tatsugami, Katsunori
- Naito, Seiji
Producer: 20150119
In:
Japanese journal of clinical oncology vol. 44
Availability: No items available.
|
|
9092.
|
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube. [electronic resource] by
- Herzog, Thomas J
- Monk, Bradley J
- Rose, Peter G
- Braly, Patricia
- Hines, Jeffrey F
- Bell, Maria C
- Wenham, Robert M
- Secord, Angeles Alvarez
- Roman, Lynda D
- Einstein, Mark H
- Drake, Richard D
- Childs, Barrett H
Producer: 20140428
In:
Gynecologic oncology vol. 132
Availability: No items available.
|
|
9093.
|
Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer. [electronic resource] by
- Garon, Edward B
- Christofk, Heather R
- Hosmer, Wylie
- Britten, Carolyn D
- Bahng, Agnes
- Crabtree, Matthew J
- Hong, Candice Sun
- Kamranpour, Naeimeh
- Pitts, Sharon
- Kabbinavar, Fairooz
- Patel, Cecil
- von Euw, Erika
- Black, Alexander
- Michelakis, Evangelos D
- Dubinett, Steven M
- Slamon, Dennis J
Producer: 20140411
In:
Journal of cancer research and clinical oncology vol. 140
Availability: No items available.
|
|
9094.
|
Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer. [electronic resource] by
- Yoo, Changhoon
- Kim, Sung-Bae
- Ro, Jungsil
- Im, Seock-Ah
- Im, Young-Hyuck
- Kim, Jee Hyun
- Ahn, Jin-Hee
- Jung, Kyung Hae
- Song, Hong Suk
- Kang, Seok Yun
- Park, Hee Sook
- Chung, Hyun-Cheol
Producer: 20180222
In:
Cancer research and treatment vol. 48
Availability: No items available.
|
|
9095.
|
|
|
9096.
|
Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents. [electronic resource] by
- Shukuya, Takehito
- Ko, Ryo
- Mori, Keita
- Kato, Motoyasu
- Yagishita, Shigehiro
- Kanemaru, Ryota
- Honma, Yuichiro
- Shibayama, Rina
- Koyama, Ryo
- Shimada, Naoko
- Takahashi, Kazuhisa
Producer: 20151217
In:
Cancer chemotherapy and pharmacology vol. 76
Availability: No items available.
|
|
9097.
|
|
|
9098.
|
|
|
9099.
|
|
|
9100.
|
|